ABUS vs UBER
Arbutus Biopharma Corp (ABUS) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the ABUS and UBER stock pages for the full models.
Not investment advice.